Study of the value of early treatment in patients with sudden blindness
Study of the value of early treatment with an endothelin inhibitor (Bosentan) in patients with sudden blindness secondary to giant cell arteritis - CECIBO Study of the value of early treatment with an endothelin inhibitor (Bosentan) in patients with sudde ...